Skip to content

Patients Undergoing Parathyroidectomy: A Randomized Controlled Trial

Opened label, randomized control trial, effect of calcitriol in preoperative parathyroidectomy to postoperative hypocalcemia and calcium replacement in dialysis patients.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20251203001
Enrollment
30
Registered
2025-12-03
Start date
2021-07-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Secondary hyperparathyroidism End-stage renal disease Hypocalcemia after parathyroidectomy Calcitriol Parathyroidectomy Hypocalcemia Renal Dialysis Chronic Kidney Disease Phosphate Binders

Interventions

Patients receive calcitriol, 2 micrograms orally once daily for three consecutive days before parathyroidectomy, together with standard calcium carbonate supplementation.,Patients do not receive preop
Calcitriol group,no calcitriol

Sponsors

King Narai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with end stage renal disease aged over 18 years who are receiving maintenance hemodialysis or peritoneal dialysis and have persistently elevated serum intact parathyroid hormone above 800 pg per mL for at least six months, together with at least one of the following despite phosphate binder therapy: 1. Serum calcium at least 10.2 mg per dL 2. Serum phosphorus above 5.5 mg per dL 3. Presence of bone pain

Exclusion criteria

Exclusion criteria: 1.Previous parathyroidectomy 2.Thyroid cancer 3.Severe comorbid conditions that contraindicate surgery 4.History of allergy to calcitriol 5.Baseline serum calcium less than 8.6 mg per dL on the day of randomization 6.Pregnant women, 7.Those who declined to participate.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative hypocalcemia Within 72 hours after surgery Serum total calcium measured by laboratory test, level less than 8.0 mg per dL

Secondary

MeasureTime frame
Total calcium supplementation requirement From postoperative day 0 until discharge Amount of intravenous and oral calcium recorded in grams per day,Duration of intravenous calcium infusion From postoperative day 0 until discharge Number of days with continuous intravenous calcium administration,Length of hospital stay From admission for surgery until discharge Total days of inpatient admission recorded in hospital chart,Treatment cost At discharge Total hospitalization cost in Thai Baht from hospital billing system

Countries

Thailand

Contacts

Public ContactTeerapon Muangpasian

King narai hospital

mteerapon@gmail.com66898806915

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026